Objective To describe corneal grafting for the treatment of full-thickness corneal defects in dogs and to determine its effectiveness in preserving vision. Methods A review of the medical records of dogs that underwent corneal grafting following corneal perforations (≥3 mm) at the VTH-UAB from 2002 to 2012 was carried out. Results Fifty dogs of different breed, age and gender were included. Brachycephalic breeds were overrepresented (37/50;74%). All cases were unilateral, with euryblepharon being the most common concurrent ocular abnormality (20/50;40%). Fullthickness penetrating keratoplasties (FTPK) were performed in 21/50 eyes (42%) and lamellar keratoplasties (LK) in 29/50 eyes (58%). Frozen grafts (FroG) were used in 43/50 eyes (86%) and fresh homologous grafts (FreHoG) in 7/50 (14%). Of the former group, 26 were homologous (FroHoG:60%) and 17 heterologous (FroHeG:40%). A combination of topical medication (antibiotics, corticosteroids, cycloplegics, and 0.2% cyclosporine A) and systemic mycophenolate mofetil was administered. Median follow-up time was 200 days. Postsurgical complications included wound dehiscence (6/50;12%) and glaucoma (4/50;8%). Clinical signs of graft rejection were diagnosed as follows: FroHoG (13/26;50%), FroHeG (11/17;65%), FreHoG (4/7;57%), FTPK (12/21;57%), and LK (16/29;55%). Medical treatment successfully controlled graft rejection in 11/28 eyes (39%). Good anatomical outcome was achieved in 86% (43/ 50), of which 95% (41/43) were visual at last examination, with moderate opacification to complete transparency of the graft present in 48.2%. Conclusions Corneal grafting is an effective surgical treatment for full-thickness corneal defects in dogs. If graft rejection is present, additional medical or surgical therapy may be necessary, achieving a highly satisfactory visual outcome.
INTRODUCTION
Corneal perforation is a frequent clinical presentation in human and veterinary ophthalmology. The causes vary mildly between species but, in people, corneal infection is the most common etiology, followed by inflammation, trauma, xerosis, exposure, neurotrophic, degeneration/ ectasia, and surgery. 1 In veterinary patients, infection, inflammation, trauma, surgery, and feline corneal sequestrum have been described as frequent causes of corneal perforation. [2] [3] [4] [5] In both human and veterinary ophthalmology, the mainstay of treatment for this presentation is surgery. Several techniques have been used in humans for this purpose such as lamellar/penetrating keratoplasty, [6] [7] [8] keratoprosthesis, 9 tissue adhesives, 10 synthetic grafts 11 , and biomaterials. 12 In domestic species, apart from these techniques, others have been developed: corneoscleral transposition, 13 conjunctival grafts, 14 amniotic and renal membrane, 15, 16 peritoneum grafts, 17 and cartilage.
Zirm transplanted both corneas of the same patient, but despite the rejection of one of the grafts, the other remained transparent, without the use of immunosuppressive medication. 19 In veterinary medicine, it was Dr. Bigger who first described corneal grafting in a pet gazelle in 1837. 20 It was not until 1957 that Dr. Holt performed the first documented homograft in a dog. 21 Corneal grafting surgery and postoperative care have evolved dramatically over the following decades. Nowadays, according to the World Health Organization, more than 120 000 corneal transplants are performed each year worldwide, and corneas are one of the most common solid tissues transplanted. 22 The modern indications for corneal transplantation in human and veterinary ophthalmology can be categorized into four groups: optical, therapeutic, tectonic, and cosmetic. 23, 24 Their use in canine, feline and equine species has had promising results 3, 4, 25 but, to the authors' knowledge, no study has determined the success rates of tectonic grafts in dogs.
The purpose of this study was to describe corneal grafting for the treatment of full-thickness corneal defects in dogs and to determine its effectiveness in preserving vision.
MATERIALS A ND ME THODS

Animals
Medical records of canine patients that underwent corneal grafting surgery for the treatment of corneal perforations (≥3 mm) at the Veterinary Teaching Hospital of the Autonomous University of Barcelona (VTH-UAB) from 2002 to 2012 were reviewed.
Data analysis consisted of breed, age, gender, concurrent ocular diseases, type of keratoplasty performed (lamellar/penetrating), corneal tissue used (homologous/ heterologous, fresh/frozen), graft size (mm), postoperative treatment, complications, follow-up time (days), graft healing time (days), and assessment of vision and graft opacification at last visit.
Ophthalmic examination
All dogs in this study underwent a complete and bilateral ophthalmic examination that consisted of Schirmer tear test I (Schering-Plough Animal Health Corporation, Union, NJ), neuro-ophthalmic examination (menace response, dazzle and pupillary light reflexes), biomicroscopy (Kowa SL-15 â ; Kowa company, Tokyo, Japan), rebound tonometry (Tonovet â ; Tiolat Oy, Helsinki, Finland), indirect funduscopic examination (Heine Omega 180 â ; Heine, Herrsching, Germany), and fluorescein test. Only, patients with positive consensual pupillary light and dazzle reflexes in the affected eye were included in the study.
Donor cornea preservation
Donor grafts were obtained from the VTH-UAB Eye Bank. This bank retrieves and stores eyes for corneal transplantation and research purposes. Donor corneal tissue was harvested from dogs, cats and horses euthanized for reasons other than systemic infection or neoplasia, and pigs' eyes obtained from a local slaughterhouse. The eyes were aseptically enucleated by subconjunctival technique. All eyes underwent routine ocular surface disinfection with povidone iodine solution (Braunol â ; B. Braun vetcare S. A., Barcelona, Spain), diluted in 1:50 saline. Each globe was then placed in a sterile container and a commercially available antibiotic solution (Oftalmotrim â ; trimethoprimsulfamethoxazole, Alcon cus ı laboratoris, El Masnou, Barcelona, Spain) was applied over it (Fig. 1) . The containers were frozen at À20°C and used as needed for a period from 1 month to 1 year. When corneas were harvested from fresh globes, the same preparation method was utilized and the eyes were preserved refrigerated (4°C) for a maximum of 48 h. At the time of surgery, preference was given to homologous fresh tissue, if possible, and if none was available, homologous and then heterologous frozen grafts were used.
General surgical considerations
Preoperative topical medication varied, as it depended on the treatment regime used by the referring veterinarian and the clinical phase of the disease prior to perforation, but it was discontinued on admission. Before surgery, all patients were administered systemic antibiotics (cephazolin 25 mg/kg intravenously [IV], Kurgan â ; Laboratorios Normon S. A., Madrid, Spain), and systemic nonsteroidal antiinflammatory drugs (flunixin meglumine 0.5 mg/kg IV, Flunixin Ynyectable Norbrook â ; Laboratorios Karizoo, S. A., Barcelona, Spain). All dogs were routinely premedicated and anesthetized; induction consisted of diazepam ; S&V Technologies AG, Hennigsdorf, Germany) was used whenever needed at the beginning of the surgery.
If frozen cornea was used, it was partially thawed at room temperature and the devitalized corneal epithelium was removed by gentle scraping with a cellulose sponge. Thereafter, the corneal defect was measured and the donor button was collected, 0.5-1 mm larger in diameter. When needed, the graft was trimmed to fit the recipient's corneal bed with corneal scissors. The graft was stabilized by initially placing four cardinal sutures at 12, 6, 9, and 3-O'clock position, using 9-0 suture materials: polyglactin 910 (Vicryl 
Lamellar graft preparation
A corneal trephine (F. C. I. Instruments Co., Paris, France) was placed over the central area of the donor cornea, and gentle downward pressure was applied in a single direction rotational movement, allowing for a clear-cut incision, with vertical sides. The thickness of the graft was 70-80% that of the recipient cornea, and the button was then obtained by keratectomy with a crescent blade knife (Ophthalmic crescent knife â ; Alcon, TX) or by sharp lamellar dissection using a 65 Beaver blade (SM65, Swann-Morton â ; Sheffield, UK) or a blade made from a sterile razorblade.
Full-thickness graft preparation
When using frozen grafts, a standard ab externo surgical approach for penetrating keratoplasty was utilized. A fullthickness button was trephined, using the previously described technique for lamellar keratoplasty, and the button placed on a corneal silicon concave stand (Teflon block), with the Descemet's membrane side up and covered with viscoelastic.
If fresh grafts were used, an ab interno technique was performed. The donor globe was sectioned, through 360°, 2 mm distal to the limbus. The tissue was then placed on a Teflon block-endothelium side up-and a penetrating keratoplasty was performed using a trephine. This technique allows a precise incision of the endothelium -vital for graft transparency.
Postoperative treatment
Postoperative treatment consisted of topical 1% cyclopentolate (Colircus ı Ciclopl ejico â ; Alcon cus ı laboratoris, Barcelona, Spain) or 1% atropine (Colircus ı Atropina â 1%; Alcon cus ı laboratoris, El Masnou, Barcelona, Spain) two to three times daily for 5-7 days, and tobramycin (Tobrex ; Roche Farma, Madrid, Spain) was administered to every patient. If nylon suture material was used, removal of the sutures was carried out in two stages; half were removed 3-4 weeks after surgery and the remaining sutures, 3 weeks later.
Graft healing time, graft rejection, vision and graft opacification assessment
Graft healing time was determined by the time it took for complete graft re-epithelization, assessed by means of a negative fluorescein uptake by the grafted cornea. If fresh donor graft was used, the corneal epithelium was not removed; therefore, graft healing time was not applicable in these eyes.
Corneal graft rejection was characterized by one of the following: epithelial, stromal or endothelial rejection bands, keratic precipitates, and increase in corneal thickness (edema).
Vision was assessed at the last visit by a board certified ophthalmologist by means of a positive menace response and/or maze test. Graft opacification was classified in five grades: transparent, mildly opaque, moderately opaque, severely opaque, and completely opaque. Grading was based on high-resolution digital photographic images (Nikon â D3100 and Sigma â EM-140 EG flash) through a computerized analysis, when available, or on the clinical description present on the patient's record.
Statistical analysis
Results are described using the median and range (min, max) for continuous variables and absolute frequencies and percentage for categorical variables. Inferential analyses for prognostic factor for outcome were performed estimating hazard ratio (HR) and their 95% confidence intervals (95% CI) by means Cox regression models. An approach for a multivariate model was made using prognostic factors with a P-value <0.10 in univariate analyses. Study of independent risk factors for glaucoma, graft rejection, or suture dehiscence was evaluated by means of odds ratio (OR), and their 95% CI by means of logistic regression models. In all analyses, a bilateral Type I error of 5% was applied without a formal correction for multiplicity. The SPSS 20 (IBM, Armonk, NY) program package was used for the statistical analyses.
RE SUL TS
Animals
A total of 50 patients were included in the study. There were 13 different breeds (Table 1) , and brachycephalic dogs were the most common (74%). There were 26 entire females, 22 entire males, one spayed female, and one neutered male. Median age was 42 months, with a range of 4-132 months.
Ophthalmic findings at first examination
In every case, the presentation was unilateral. The right eye was affected in 19/50 (38%) patients and the left eye in 31/50 (62%). Euryblepharon was the most common concurrent ocular disease in 20/50 (40%), but entropion in 7/50 (14%), trichiasis in 6/50 (12%), keratoconjunctivitis sicca in 6/50 (12%), distichiasis in 3/50 (6%), prolapsed gland of the nictitating membrane in 1/50 (2%), and lagophthalmia in 1/50 (2%) were also diagnosed.
Type and size of the corneal grafts
Lamellar grafts were performed in 29 eyes (58%) and fullthickness grafts in 21 (42%). In 7 (14%) keratoplasties, fresh homologous tissue was used (Fig. 2) , and in 43 (86%) frozen tissue, of which 26 were homologous (60%) (Fig. 3 ) and 17 heterologous (40%) (Fig. 4) .
Graft size ranged from 3 to 15 mm, with a median of 7.5 mm in diameter.
Polyglactin 910 suture material was used in 31 cases (62%) and nylon in 19 (38%). At the time of surgery, the following procedures were performed concurrently: canthoplasty in 19 cases (38%); and phacoemulsification; Morgan-Moore technique; nasal fold resection; Hotz-Celsus; and eyelid cryosurgery, a single case each (2%).
Follow-up, graft healing time, and complications
Follow-up time ranged from 34 days to 6 years (median = 0.55 years). Complete graft healing time ranged from 4 to 62 days with a median of 24 days. The three main complications observed during the study are shown in Table 2 . As seen in Table 3 , diagnosis of glaucoma became statistically significant in larger sized grafts, OR: 1.96 (95% CI 1.08; 3.54).
In cases where graft rejection was detected, medical therapy was used as the first therapeutic approach; and in nonresponsive cases, when the eye could be salvaged, conjunctival graft surgery was performed. In the former group, 11 of 28 cases (39%) were successfully managed with additional use of topical dexamethasone phosphate, hypertonic solution, 0.2% CsA, and systemic MM. Four eyes could not be salvaged, but the remaining 13 refractory patients underwent surgery to control rejection, and 85% (11/13) responded positively.
Outcome and graft opacification
Anatomical outcome was classified as good in 86% of the cases (43/50). Of these, 41 eyes (95%) were visual at last examination. Among the studied variables ( Table 4) that could affect the anatomical and visual outcome, the graft's size, with HR: 1.41 (95% CI 1.07; 1.85) and origin, with HR: 15.75 (95% CI 1.51; 163.54) for frozen heterologous, were the only two that showed statistical significant risk factors. A poor anatomical outcome was directly associated with larger sized grafts, HR: 1.53 (95% CI 1.08; 2.16). As for the origin of the tissue, the group that had the lowest risk of poor outcome was frozen homologous, followed by fresh homologous and lastly frozen heterologous, for more details see Table 4 . Furthermore, a synergistic effect between the origin and size of the graft was observed in the multivariable study. When frozen heterologous and fresh homologous grafts were used, the larger they were, the higher the likelihood of a poor outcome (HR: 33.41 [95% CI 2.34; 477. 47] and HR: 13.67 [95% CI 1.00; 187.14], respectively).
Opacification of the graft could only be determined in 29 cases, as the remaining patients either underwent conjunctival graft surgery (13/50;26%) or the eye was lost due to secondary complications (7/50;14%) and in one case the patient died during the postoperative period. The corneal graft remained transparent in 3/29 cases (10.3%) (Fig. 2c) , mildly opaque in 5/29 (17.2%) (Fig. 5a) , moderately opaque in 6/29 (20.7%) (Fig. 5b) , severely opaque in (Fig. 5c) , and completely opaque in 10/29 (34.5%) (Fig. 3c) .
DISCUSSION
Full-thickness corneal defects (≥3 mm) represent an ophthalmological emergency, threatening both vision and preservation of the patient's globe. Different surgical techniques have been described but to the authors' knowledge, no study has determined the success rates of tectonic grafts in dogs for the treatment of corneal perforations. The present study shows that surgical management of these cases using corneal grafting is very efficient, whilst achieving good anatomical and visual outcomes (86% [43/ 50] and 82% [41/50] , respectively). In veterinary medicine, other surgical techniques apart from keratoplasties have been reported to successfully manage corneal perforations such as: grafts of equine amniotic membrane, 15 grafts of porcine small intestine submucosa (SIS), 26, 27 autologous conjunctival grafts 14, 28 , and corneoscleral or corneoconjunctival transposition (CCT) grafts. 13 Equine amniotic membrane grafts have been associated with marked granulation tissue formation and opacification of the graft, and its use is only recommended for peripheral corneal lesions. 15 Furthermore, the preparation of amniotic membrane for transplantation is moderately complex 29 and availability is limited, thus not making this method easily accessible to all clinicians. The use of SIS for the treatment of corneal perforations has been described as a single procedure 27 or in combination with conjunctival pedicle graft. 26 Regarding the former description, it is worth mentioning that there is no information available about the size of the corneal lesions treated. 27 Similarly, in the study of SIS and conjunctival pedicle graft, the size of the corneal lesions was not provided for every case of corneal perforation but, for the ones it was, the largest was 3 mm. In these small lesions, the opacification secondary to the conjunctival graft may not be significant and the patient may retain vision, but in larger defects it might compromise visual outcome. Therefore, based on these reports it is not possible to establish how useful this method is in treating large full-thickness defects. Although, as previously described, conjunctival and CCT grafts have also been used for the treatment of corneal perforations, their use in large corneal perforation is controversial, mainly due to the lack of an efficient tectonic support, the need for healthy cornea to serve as autologous graft and the limited size of corneal lesions in which they can be used (defects smaller than 25-30% of the corneal diameter). 30 These limitations are not present in corneal grafting.
In human ophthalmology, the success rate of corneal grafting surgery is dependent on the immunologic/clinical state of the recipient cornea. Keratoplasties for the treatment of noninflammatory corneal dystrophies have higher success rates (from 88% [1 year postoperative] to 62% [10 years postoperative]) 31 than keratoplasties for acquired degenerative corneal diseases, which have higher rates of rejection. [31] [32] [33] [34] [35] In the latter group, corneal inflammation, infection and/or vascularization are responsible for most of the rejected or failed grafts. [31] [32] [33] [34] [35] [36] [37] The rejection rates range from values as low as 0-10% in avascular recipient corneas, 35 to values as high as 25-50% in severely vascularized corneas. 34 In fact, vascularization has been determined to be the most important risk factor for rejection. The risk of graft failure is directly associated with the number of blood vessels per corneal quadrant if they cross at least 2 mm from the limbus. 32, 34 Although in humans the rejection rate of penetrating keratoplasties is well known, ranging from 25 to 65% (50-65% of which respond to medical treatment), 32, 35 in veterinary medicine, there are no similar reports. The present study is the first to determine the rejection rate of penetrating keratoplasties in dogs (rejection rate of 56%), which is in accordance with what has been previously described in humans. Furthermore, it is worth mentioning that all eyes in this study were considered to be at high risk of failure or rejection as the grafts were placed in inflamed and vascularized corneas, and in large corneal defects. Therefore, it is possible to hypothesize that, as in humans, corneal grafting for the treatment of nonvascular, noninflamed pathologies, could be associated with a lower rejection rate.
Despite the high rejection rates detected in the present study, the anatomical and visual outcome was high (86% and 82%, respectively). These favorable results are certainly associated with the medical management of rejection. In humans, reducing the donor antigen tissue load and suppressing the host immune response have been shown to prevent corneal graft rejection. 32 For this purpose, the recommended medical management for the prevention of corneal rejection consists of topical and systemic corticosteroids, both pre-and postoperatively, 32, 34 and topical and systemic cyclosporine A (CsA). 32 In the present study, all patients were prescribed topical corticosteroids (three times daily) and 0.2% CsA (twice daily) immediately after surgery.
Mycophenolate mofetil has shown similar 38 to slightly better 39 effectiveness than CsA, although with fewer side effects, in preventing acute rejection following high-risk corneal transplantation. 38, 40 Mycophenolate mofetil is commonly used in patients undergoing solid organ transplantation or hematopoietic cell transplantation, 41 and in veterinary medicine, it has been used for acquired myasthenia gravis, 42 control of renal allograft rejection, 43 immune-mediated hemolytic anemia, and Pemphigus vulgaris. 44 The recommended dose range is 10-20 mg/kg per os every 12 h, but gastrointestinal hemorrhage, anorexia, and diarrhea have been reported in dogs. 43 To reduce the toxicity levels, a 15 mg/kg daily dose was used, as it has (a) (b) (c) Figure 4 . Frozen heterologous 9 mm full-thickness keratoplasty in a 8 year-old male Pug with corneal perforation (a). Post-operative result after 10 days (b). Note the graft opacification, corneal neovascularization and corneal pigmentation 2 months after surgery, in an otherwise potentially visual eye (c). shown to have a bioavailability of 65%. 41 All the patients medicated with MM were free of adverse reactions.
Apart from the standard medication for prevention of corneal rejection, every patient in which rejection was clinically diagnosed (n = 28;56%) received an increased frequency of topical corticosteroids (six times daily) and topical 0.2% CsA (four times daily). This medical strategy, applied at the appropriate time, successfully managed 39% (11/28) of rejections, preserving vision in the affected eyes.
The present study agrees with previous reports in human beings, where poor outcomes (anatomical and visual) were associated with larger grafts, 32, 37, 45 and their proximity to the limbus; as the Langerhans cells that express class II antigens are primarily located in the peripheral cornea. [32] [33] [34] Furthermore, and contrary to previous research, this study identifies a significant difference between the origin of the graft donor tissue and the presence of postoperative complications (i.e., corneal vascularization, corneal edema, or opacification of the graft), the latter being more frequent in frozen heterologous grafts and less frequent in fresh homologous tissue. 46 However, it is well known that the immunologic recognition in fresh donor corneal grafts is directed mainly toward corneal endothelium and epithelium, 47 which means that fresh full-thickness grafts have a greater risk of rejection.
Apart from clinical rejection, other identified complications included secondary glaucoma (4/50;8%) and wound dehiscence (6/50;12%), which have been previously reported in both human and dogs. 3, 34, 48, 49 Similar to what has been previously described in people, the risk of glaucoma statistically increased when larger grafts were used associated with the possible formation of pre-iridal fibrovascular membranes (PIFM) and/or secondary peripheral anterior synechiae at the graft host junction. 32, 48 In the present study, no statistically significant variables were associated with suture dehiscence. The choice of suture material was based on the balance between restoring maximal visual acuity vs. tectonic support. In those cases where size and location of the graft allowed for a good recovery of vision, a nonabsorbable suture material (nylon) was used. When the size of the graft was significantly larger, and the main goal of surgery was globe preservation (good anatomical outcome), an absorbable suture (polyglactin 910) was used. The recommendation in cases where the reason for grafting is optical is to use nylon, a nonreactive suture material, and therefore less likely to attract inflammatory cells.
2,31
The decision to use lamellar 3, 4, 50, 51 or full-thickness grafts 49, 52, 53 was mostly an historical one, as statistically there was no significant difference between groups. With the recent updates 54, 55 in corneal microsurgical techniques and donor and postoperative recipient tissue responses to grafting (reduced degree of immediate postoperative edema), lamellar keratoplasty has become the technique of choice, regardless of location or size of the corneal lesion.
The success of corneal grafting for the treatment of full-thickness defects is achieved when the cornea is repaired and the patient retains vision after treatment. Although complete transparency to moderate opacification of the graft was present in 48.2% of the cases (14/29), the overall results of this study are very promising (86% of the eyes with good anatomical outcome, of which 95% were visual at last examination). In recent publications 2, 25 , there has been mention of possible migration of endothelial cells adjacent to the donor button, allowing for the frozen graft to become transparent months after surgery. The same event has been witnessed in this study in some of the smaller sized grafts, supporting that this endothelium behavior is an encouraging factor for vision recovery. The use of fresh grafts would assure a more transparent cornea, as endothelial cells are preserved. However, in high-risk corneas, the immune response toward the endothelium and epithelium is more severe; therefore, a careful decision must be made before choosing fresh tissue. A second procedure, using fresh cornea, was offered when opacification and size of the graft were significant. However, most owners were reluctant to proceed as they were pleased with the normal visual behavior shown by their dog. One of the potential limitations of the present study was the reduced number of cases. However, they are a representative sample of what is found in everyday practice, providing a valid and strong interpretation of the results. The postoperative treatment regime varied amongst patients, which may justify why similar cases responded differently. This fact was due to the newer studies and drugs that become available and that helped control graft rejection more efficiently.
In conclusion, corneal grafting is an effective surgical treatment for full-thickness corneal defects in dogs. If graft rejection is present, additional medical or surgical therapy may be necessary, achieving a highly satisfactory visual outcome.
